Fasiha Kanwal

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 21

Top Topics

Fluorescence Imaging

Palliative Care

Papillary Thyroid

Top Venues

Hepatology (Baltimore, Md.)

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Hepatology communications

This page only lists publications with an associated author ORCID identifier.

Publications

Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Hashem E El-Serag, Fasiha Kanwal, Jing Ning, Hannah Powell, Saira Khaderi, Amit G Singal, Sumeet Asrani, Jorge A Marrero, Christopher I Amos, Aaron P Thrift, Michelle Luster, Abeer Alsarraj, Luis Olivares, Darlene Skapura, Jenny Deng, Emad Salem, Omar Najjar, Xian Yu, Hao Duong, Michael E Scheurer, Christie M Ballantyne, Salma Kaochar
Serum biomarker signature is predictive of the risk of hepatocellular cancer in patients with cirrhosis. Gut (2024)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2023)
Arpan A Patel, Elliot B Tapper, Fasiha Kanwal, Christopher D Woodrell, Lissi Hansen, Jennifer C Lai, Shari S Rogal, Cara McDermott, Mina Rakoski, Nneka N Ufere
Targets and study design for symptom-focused trials aimed at patients with cirrhosis: An expert consensus. Hepatology communications 7 (6) (2023)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 79 (5) (2023)
Fasiha Kanwal, Brent A Neuschwander-Tetri, Stephen Caldwell, Mary E Rinella
Metabolic dysfunction-associated steatotic liver disease: Update and impact of new nomenclature on the American Association for the Study of Liver Diseases practice guidance on nonalcoholic fatty liver disease. Hepatology (Baltimore, Md.) 79 (5) (2023)
Jennifer R Kramer, Yamini Natarajan, Jianliang Dai, Xian Yu, Liang Li, Hashem E El-Serag, Fasiha Kanwal
Reply. Hepatology (Baltimore, Md.) 76 (2) (2022)
Saira Khaderi, Fasiha Kanwal
Changing epidemiology of hepatocellular cancer in the United States: Winning the battle but it is not over yet. Hepatology (Baltimore, Md.) 76 (3) (2022)
Shari S Rogal, Lissi Hansen, Arpan A Patel, Nneka N Ufere, Manisha Verma, Christopher D Woodrell, Fasiha Kanwal
AASLD Practice Guidance: Palliative care and symptom-based management in decompensated cirrhosis. Hepatology (Baltimore, Md.) 76 (3) (2022)
Marina Serper, Neehar D Parikh, Grace Thiele, Nadia Ovchinsky, Shivang Mehta, Alexander Kuo, Chanda Ho, Fasiha Kanwal, Michael Volk, Sumeet K Asrani, Marwan S Ghabril, John R Lake, Raphael B Merriman, Timothy R Morgan, Elliot B Tapper
Patient-reported outcomes in HCC: A scoping review by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.) 76 (1) (2022)
Fasiha Kanwal, Saira Khaderi, Amit G Singal, Jorge A Marrero, Nicole Loo, Sumeet K Asrani, Christopher I Amos, Aaron P Thrift, Xiangjun Gu, Michelle Luster, Abeer Al-Sarraj, Jing Ning, Hashem B El-Serag
Risk factors for HCC in contemporary cohorts of patients with cirrhosis. Hepatology (Baltimore, Md.) (2022)
Peter Lymberopoulos, Sameer Prakash, Anjiya Shaikh, Anshul Bhatnagar, Anthony K Allam, Karthik Goli, John A Goss, Fasiha Kanwal, Abbas Rana, Kris V Kowdley, Prasun Jalal, null George Cholankeril
Long-term outcomes and trends in liver transplantation for hereditary hemochromatosis in the United States. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2022)
Mounika Kanneganti, Jorge A Marrero, Neehar D Parikh, Fasiha Kanwal, Takeshi Yokoo, Mishal Mendiratta-Lala, Nicole E Rich, Purva Gopal, Amit G Singal
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 28 (12) (2022)
George Cholankeril, Alsadiq Al-Hillan, Brandon Tarlow, Daniela Abrams, Jake S Jacobs, Norma P Flores, Abbas Rana, Fasiha Kanwal, John A Goss
Clinical Factors Associated With Lack of Serological Response to SARS-CoV-2 Messenger RNA Vaccine in Liver Transplantation Recipients. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (2021)
Jennifer R Kramer, Yamini Natarajan, Jianliang Dai, Xian Yu, Liang Li, Hashem El-Serag, Fasiha Kanwal
Effect of diabetes medications and glycemic control on risk of hepatocellular cancer in patients with non-alcoholic fatty liver disease. Hepatology (Baltimore, Md.) (2021)
Sumeet K Asrani, Marwan S Ghabril, Alexander Kuo, Raphael B Merriman, Timothy R Morgan, Neehar D Parikh, Nadia Ovchinsky, Fasiha Kanwal, Michael L Volk, Chanda Ho, Marina Serper, Shivang Mehta, Vatche G Agopian, Roniel Cabrera, Victoria Chernyak, Hashem B El-Serag, Julie Heimbach, George N Ioannou, David Kaplan, Jorge Marrero, Neil Mehta, Amit G Singal, Riad Salem, Tamar Taddei, Anne Walling, Elliot B Tapper
Quality measures in HCC care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md.) (2021)
Fasiha Kanwal, Jennifer R Kramer, Liang Li, Jianliang Dai, Yamini Natarajan, Xian Yu, Steven M Asch, Hashem E El-Serag
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 71 (3) (2020)